Receptor activator of NF-kappaB recruits multiple TRAF family adaptors and activates c-Jun N-terminal kinase
about
A novel zinc finger protein that inhibits osteoclastogenesis and the function of tumor necrosis factor receptor-associated factor 6Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6RANK-RANKL signalling in cancerRoles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functionsTRAF1 is a substrate of caspases activated during tumor necrosis factor receptor-alpha-induced apoptosisElucidation of CPX-1 involvement in RANKL-induced osteoclastogenesis by a proteomics approach.Development of cell-based high-throughput assays for the identification of inhibitors of receptor activator of nuclear factor-kappa B signaling.Signal transduction by tumour necrosis factor and tumour necrosis factor related ligands and their receptors.Osteoblast Role in Rheumatic Diseases.Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interactionTRP14 inhibits osteoclast differentiation via its catalytic activitySelective targeting of RANK signaling pathways as new therapeutic strategies for osteoporosis.The emerging field of osteoimmunologyMechanisms balancing skeletal matrix synthesis and degradation.2-Methoxystypandrone represses RANKL-mediated osteoclastogenesis by down-regulating formation of TRAF6-TAK1 signalling complexesRegulatory mechanisms of osteoblast and osteoclast differentiation.(+)-Vitisin A inhibits osteoclast differentiation by preventing TRAF6 ubiquitination and TRAF6-TAK1 formation to suppress NFATc1 activationOsteoclasts: New InsightsSignaling networks that control the lineage commitment and differentiation of bone cells.RANK (TNFRSF11A) is epigenetically inactivated and induces apoptosis in gliomas.Molecular regulatory mechanisms of osteoclastogenesis through cytoprotective enzymes.Functions of RANKL/RANK/OPG in bone modeling and remodeling.The Keap1/Nrf2 protein axis plays a role in osteoclast differentiation by regulating intracellular reactive oxygen species signaling.Meningioma 1 is required for appropriate osteoblast proliferation, motility, differentiation, and function.NF-kappaB p100 limits TNF-induced bone resorption in mice by a TRAF3-dependent mechanism.Interaction of staphylococci with bone.Osteoclastogenesis and arthritis.Why TNF-α inhibition is not sufficient to avoid juxta-articular erosions in chronic arthritis?Bisphosphonates: effects on osteoblast.Emerging therapeutic targets for osteoporosis treatment.12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation.Osteoblast-osteoclast interactions.Role of FK506 binding protein 5 (FKBP5) in osteoclast differentiation.Osteoblast role in osteoarthritis pathogenesis.High expression levels of IKKalpha and IKKbeta are necessary for the malignant properties of liver cancer.Membrane rafts play a crucial role in receptor activator of nuclear factor kappaB signaling and osteoclast function.Stimulation of osteoprotegerin (OPG) gene expression by transforming growth factor-beta (TGF-beta). Mapping of the OPG promoter region that mediates TGF-beta effects.RANKL cytokine enhances TNF-induced osteoclastogenesis independently of TNF receptor associated factor (TRAF) 6 by degrading TRAF3 in osteoclast precursors.Thapsigargin modulates osteoclastogenesis through the regulation of RANKL-induced signaling pathways and reactive oxygen species production.The role of TNF-α and TNF superfamily members in the pathogenesis of calcific aortic valvular disease.
P2860
Q24292059-DC2B1396-15B4-4841-B83B-E62930F49FCDQ24537518-6567543D-02C6-45A7-B8A6-DAF359E6D65CQ26747442-76917854-4D12-425B-94F7-2A36993F159FQ26853280-05B4526B-EFFB-49D0-9BF2-D3979128A5CFQ28138885-1596B92D-CC6F-4D82-821B-E2003796F576Q33201894-434DDBB5-51B0-4791-9401-DE9E5458961BQ33738074-8022FBD3-E6D3-482C-B922-3146AED83A10Q33782305-144A24E9-D2EC-4664-B757-65ECA1F28171Q33838967-BB02C958-E6B0-4921-8628-D0FEC2F925CDQ33886695-0C569B44-DB81-4B8C-B64E-7300D7C9F623Q34056632-08336BA8-C15A-4DA0-B1F3-D77CD78F4BCCQ34090842-563249E8-2BF0-4078-A1E0-5BA1C6679E6FQ34108110-6AF801A7-96A1-48A9-A4BD-FA177114B9A1Q34129759-6AA0DBA2-C679-4E32-BABF-A734550A4A89Q34339766-55E9CAF7-8C4B-428F-B8C3-5EBD53CEAC1DQ34728971-33171274-00DE-4522-818C-63C32C97E6BAQ35099825-836FB466-71FE-40FD-9973-6E1B58198E7EQ35755039-7631D610-6073-4B00-A49D-D978BF33FF5CQ36082866-67A8621C-E0BA-4F8D-B4DF-B21076143DFBQ36088188-64FD183F-F608-48ED-9246-88BB60270D06Q36517710-F1CD07FF-E956-4FB0-A303-C17EBE1BB32AQ36700779-AFB0172A-B59A-4510-B853-2478F2A19084Q37095379-AD8DEB43-8D3E-48C2-B20E-AF52F1806E0CQ37258568-6AEC686F-601C-4A39-8081-E9ED285727A4Q37363042-82342AE7-1A77-46B1-BC8C-9A8E00BC507CQ37627430-01026E6B-0021-4A88-BF7C-E4274A127F9BQ37808649-9E7048BC-2FC1-47AA-8534-EB87812BC681Q37836495-3142A113-402F-42B3-8799-647653EF0039Q37982663-9D7A7031-0D12-47EE-94C7-958D750C3CF2Q38207147-0D68B93D-1621-4D9F-BF91-E2EB2D66583DQ38346899-B9F0EB44-2C91-4BB7-A590-A8374AE584E3Q39190775-21BD4306-8B3F-48D4-BD6D-7DB3A4568EECQ39221657-45756305-F53C-4A89-B86F-D7B161C47059Q39251652-D16E0D9A-0EE3-476E-82E9-ACB513818A11Q39804025-C34718C5-D1C8-45AB-ADB7-378679B91A7BQ40663935-296F4226-4356-4B04-8517-2FA34F6FB19BQ40792736-41A04D10-6AEA-41CA-BA68-4CCDE763110AQ41912868-DF857F99-9F44-4E21-B420-62577C8FC02DQ46592953-483EA65B-4777-4302-9464-209861C50301Q54487255-32647BCF-62ED-4B33-9357-3ED78BECDB95
P2860
Receptor activator of NF-kappaB recruits multiple TRAF family adaptors and activates c-Jun N-terminal kinase
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Receptor activator of NF-kappa ...... ivates c-Jun N-terminal kinase
@ast
Receptor activator of NF-kappa ...... ivates c-Jun N-terminal kinase
@en
Receptor activator of NF-kappa ...... ivates c-Jun N-terminal kinase
@nl
type
label
Receptor activator of NF-kappa ...... ivates c-Jun N-terminal kinase
@ast
Receptor activator of NF-kappa ...... ivates c-Jun N-terminal kinase
@en
Receptor activator of NF-kappa ...... ivates c-Jun N-terminal kinase
@nl
prefLabel
Receptor activator of NF-kappa ...... ivates c-Jun N-terminal kinase
@ast
Receptor activator of NF-kappa ...... ivates c-Jun N-terminal kinase
@en
Receptor activator of NF-kappa ...... ivates c-Jun N-terminal kinase
@nl
P2093
P2860
P3181
P1433
P1476
Receptor activator of NF-kappa ...... ivates c-Jun N-terminal kinase
@en
P2093
P2860
P304
P3181
P356
10.1016/S0014-5793(98)01731-1
P407
P577
1999-01-29T00:00:00Z